Atlas Trials

Mapi Pharma Ltd.

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Mapi Pharma Ltd.

RecordFirmDate
Safety, Tolerability and Efficacy of Semaglutide Depot in Subjects With Type-2 Diabetes Mellitus (NCT07563699)Mapi Pharma Ltd.2026-08-09
Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine (NCT07185815)Mapi Pharma Ltd.2025-08-01
A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects With RMS (NCT04121221)Mapi Pharma Ltd.2019-09-19
Safety and Efficacy of Monthly Long-acting IM Injection of 25mg or 40 mg GA Depot in Subjects With PPMS (NCT03362294)Mapi Pharma Ltd.2017-12-11
Safety, Tolerability and Efficacy of Monthly Long-acting IM Injection of 80 or 40 mg GA Depot in Subjects With RRMS (NCT02212886)Mapi Pharma Ltd.2014-10-01

Track Mapi Pharma Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.